- Home
- SHO vs MNKD Comparison
SHO vs MNKD Comparison
Compare SHO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHO
- MNKD
- Stock Information
- Founded
- SHO 1995
- MNKD 1991
- Country
- SHO United States
- MNKD United States
- Employees
- SHO N/A
- MNKD N/A
- Industry
- SHO Hotels/Resorts
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- SHO Consumer Discretionary
- MNKD Health Care
- Exchange
- SHO Nasdaq
- MNKD Nasdaq
- Market Cap
- SHO 2.3B
- MNKD 1.9B
- IPO Year
- SHO 1995
- MNKD 2004
- Fundamental
- Price
- SHO $11.02
- MNKD $5.51
- Analyst Decision
- SHO Hold
- MNKD Buy
- Analyst Count
- SHO 7
- MNKD 6
- Target Price
- SHO $11.86
- MNKD $8.92
- AVG Volume (30 Days)
- SHO 2.3M
- MNKD 2.0M
- Earning Date
- SHO 02-21-2025
- MNKD 02-25-2025
- Dividend Yield
- SHO 3.24%
- MNKD N/A
- EPS Growth
- SHO 89.56
- MNKD N/A
- EPS
- SHO 0.76
- MNKD 0.08
- Revenue
- SHO $910,264,000.00
- MNKD $267,200,000.00
- Revenue This Year
- SHO N/A
- MNKD $44.15
- Revenue Next Year
- SHO $9.58
- MNKD $19.65
- P/E Ratio
- SHO $14.66
- MNKD $70.51
- Revenue Growth
- SHO N/A
- MNKD 51.35
- 52 Week Low
- SHO $9.39
- MNKD $3.22
- 52 Week High
- SHO $12.41
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- SHO 33.46
- MNKD 28.96
- Support Level
- SHO $10.92
- MNKD $5.46
- Resistance Level
- SHO $11.61
- MNKD $6.23
- Average True Range (ATR)
- SHO 0.25
- MNKD 0.19
- MACD
- SHO -0.07
- MNKD -0.04
- Stochastic Oscillator
- SHO 9.41
- MNKD 5.77
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. Sunstone's sole source of income is hotel revenue from its hotel ownership segment.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.